[1-Cyclopropyl-2-(4-ethylphenoxy)ethyl]amine
![[1-Cyclopropyl-2-(4-ethylphenoxy)ethyl]amine price.](/CAS/20140525/GIF/CB82690764.gif)
|
- $320 - $904
- Product name: [1-Cyclopropyl-2-(4-ethylphenoxy)ethyl]amine
- CAS: 1341840-61-6
- MF: C13H19NO
- MW: 205.3
- EINECS:
- MDL Number:MFCD19605893
- Synonyms:[1-Cyclopropyl-2-(4-ethylphenoxy)ethyl]amine;Cyclopropanemethanamine, α-[(4-ethylphenoxy)methyl]-
4 prices
Selected condition：
Brand
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- 5g
- ManufacturerCrysdot
- Product numberCD12152759
- Product description1-Cyclopropyl-2-(4-ethylphenoxy)ethanamine 97%
- Packaging1g
- Price$320
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12152759
- Product description1-Cyclopropyl-2-(4-ethylphenoxy)ethanamine 97%
- Packaging5g
- Price$904
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number080409
- Product description[1-Cyclopropyl-2-(4-ethylphenoxy)ethyl]amine
- Packaging500mg
- Price$336
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number080409
- Product description[1-Cyclopropyl-2-(4-ethylphenoxy)ethyl]amine
- Packaging1g
- Price$420
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Crysdot | CD12152759 | 1-Cyclopropyl-2-(4-ethylphenoxy)ethanamine 97% | 1g | $320 | 2021-12-16 | Buy |
| Crysdot | CD12152759 | 1-Cyclopropyl-2-(4-ethylphenoxy)ethanamine 97% | 5g | $904 | 2021-12-16 | Buy |
| Matrix Scientific | 080409 | [1-Cyclopropyl-2-(4-ethylphenoxy)ethyl]amine | 500mg | $336 | 2021-12-16 | Buy |
| Matrix Scientific | 080409 | [1-Cyclopropyl-2-(4-ethylphenoxy)ethyl]amine | 1g | $420 | 2021-12-16 | Buy |
Properties
Boiling point :324.3±25.0 °C(Predicted)
Density :1.059±0.06 g/cm3(Predicted)
pka :8.80±0.33(Predicted)
Density :1.059±0.06 g/cm3(Predicted)
pka :8.80±0.33(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|